mitra复杂的几何变化加剧过导管大动脉置换后的 mitra 狭窄
Naoko Ichikawa1, Yumi Shiina2, Yuina Koashi1
1Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
The international journal of cardiovascular imaging
|July 6, 2024
概括
过导管大动脉置换 (TAVR) 可能会恶化额头气狭窄 (MS) 由于额头气复合体几何学的变化. 较小的额头环形直径和受限的叶片移动性是TAVR后MS恶化的关键预测因素.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 医疗成像医学成像
背景情况:
- 严重的大动脉狭窄症 (AS) 经常与 mitra 狭窄症 (MS) 共同存在.
- 额叶狭窄症 (MS) 恶化 透气管后大动脉置换 (TAVR) 是一种已知的并发症,具有多因素原因.
- 中心复合体的几何变化可能导致TAVR后的MS恶化,特别是在左心室小的老年患者中.
研究的目的:
- 在TAVR之前和之后调查中肌复杂的几何变化.
- 为了确定TAVR后多发性硬化症恶化的预测因素.
- 在这些变化方面,将TAVR与外科主动脉置换 (SAVR) 进行比较.
主要方法:
- 对接受TAVR或SAVR治疗严重AS的成年患者的回顾性分析.
- 胸外心声扫描以评估额头膜区域 (MVA),前额头膜传单 (AMVL) 角度和长度,额头环直径和左心室 (LV) 大小.
- 多变量分析以确定MS恶化的预测因素.
主要成果:
- 在TAVR后 (2.3至1.9厘米) 观察到MVA指数的下降.
- 在TAVR后,AMVL和LVOT之间的角度增加了 (56.3°至67.3°).
- 较小的额头环形直径,受限的AMVL移动性和植入深度是TAVR后MS恶化的显著预测因素.
结论:
- mitra复合体的几何变化,包括环状收窄和受限制的传单运动,有助于TAVR后的MS恶化.
- mitra环形直径,AMVL移动性和设备植入深度是影响TAVR后MS结果的关键因素.
- 这些发现凸显了手术前对腹解剖学的评估对于预测和潜在地减轻TAVR后多发性硬化症恶化的重要性.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...


